• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Nanoscale Fabrication, Optimization, Scale-up and Biological Aspects of Pharmaceutical Nanotechnology

    Nanoscale Fabrication, Optimization, Scale-up and Biological Aspects of Pharmaceutical Nanotechnology by Grumezescu, Alexandru Mihai;

    Series: Pharmaceutical Nanotechnology;

      • GET 10% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice EUR 171.00
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        70 922 Ft (67 545 Ft + 5% VAT)
      • Discount 10% (cc. 7 092 Ft off)
      • Discounted price 63 830 Ft (60 791 Ft + 5% VAT)

    70 922 Ft

    db

    Availability

    printed on demand

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher Elsevier Science
    • Date of Publication 29 November 2017

    • ISBN 9780128136294
    • Binding Paperback
    • No. of pages696 pages
    • Size 234x190 mm
    • Weight 1430 g
    • Language English
    • 0

    Categories

    Long description:

    Nanoscale Fabrication, Optimization, Scale-up and Biological Aspects of Pharmaceutical Nanotechnology focuses on the fabrication, optimization, scale-up and biological aspects of pharmaceutical nanotechnology. In particular, the following aspects of nanoparticle preparation methods are discussed: the need for less toxic reagents, simplification of the procedure to allow economic scale-up, and optimization to improve yield and entrapment efficiency. Written by a diverse range of international researchers, the chapters examine characterization and manufacturing of nanomaterials for pharmaceutical applications. Regulatory and policy aspects are also discussed.

    This book is a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about how nanomaterials can best be utilized.

    More

    Table of Contents:

    1. Fabrication of polymeric core-shell nanostructures
    2. Emulsification-diffusion method to obtain polymeric nanoparticles: two decades of research
    3. Tools and Techniques for the optimized synthesis, reproducibility and scale up of desired nanostructures from plant derived material and their role in pharmaceutical properties
    4. Scale up of biopharmaceuticals production
    5. Physicochemical and morphological characterization of pharmaceutical nanocarriers and mathematical modelling of drug encapsulation/release mass transfer processes
    6. Biopharmaceutics and pharmacokinetics of multifunctional nanoparticles
    7. Technological delivery systems to improve biopharmaceutical properties
    8. From physicochemically stable nanocarriers to targeted drug delivery: in-vivo pharmacokinetic, pharmacodynamic and biodistribution studies
    9. Sterile dosage forms loaded nanosystems for parenteral, nasal, pulmonary and ocular administration
    10. Quantitative Characterization of Targeted Nanoparticulate Formulations for Prediction of Clinical Efficacy
    11. Analytical tools for reliable in vitro and in vivo performance testing of drug nanocrystals
    12. Application of one-step affinity purification of drug-binding proteins with practical magnetic nanoparticles to drug discovery
    13. Molecularly Imprinted Polymers as Separation Tools
    14. Detection of DNA damage induced by nanomaterials
    15. Pharmacological usage of an enzyme inhibitor - a selective inhibitor of 3-mercaptopyruvate sulfurtransferase reaction intermediate to control generation of polysulfide
    16. Regulatory Consideration in Nanotechnology Based Drug Products

    More
    0